Sealonix is a Bedford, MA-based biomaterials company founded in January 2023 by Amar Sawhney that is developing next-generation hemostatic sealants for surgical use. Its initial product, the PramStat patch, is designed to provide rapid hemostasis in abdominopelvic and orthopedic procedures and to bioabsorb within a week after implantation. The company leverages biomaterials expertise to create surgical sealants intended for rapid bleeding control. Sealonix intends to use the funds from its recent financing to grow its development team and execute clinical trials. Founder Amar Sawhney has previously founded Confluent Surgical, Ocular Therapeutix, Augmenix, Instylla, and Rejoni.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

May 2023